Matt Hancock speaks out on AstraZeneca and Oxford Univeristy vaccine

The transcript discusses the Oxford AstraZeneca vaccine, highlighting its effectiveness of up to 90% in the right dosage. It emphasizes the importance of regulatory approval by the MHRA and outlines plans for vaccine rollout in the New Year. The vaccine is easier to administer than the Pfizer vaccine due to less stringent storage requirements. The speaker also touches on the ongoing strategy to suppress the virus while supporting the economy, education, and the NHS until widespread vaccination is achieved. Christmas plans are being coordinated across the UK, respecting discussions between devolved administrations and the government.

Why is the Oxford AstraZeneca vaccine considered easier to administer than the Pfizer vaccine?

What is the significance of having an agreed set of plans across the Four Nations of the UK?